Treatment with erlotinib in 58-year old woman with liver damage and depression as the first sign of metastases to the central nervous system

Marcin Gołecki

View PDF (polish)

47-years-old woman diagnosed with four stage lung adenocarcinoma

Barbara Huras

View PDF (polish)

EGFR mutated (exon 21) metastatic lung adenocarcinoma in female patient treated with erlotinib — case report

Krzysztof Leśniewski-Kmak

View PDF (polish)

Molecular diagnostic in a patient with adenocarcinoma of the lung treated with erlotinib

Sławomir Mańdziuk, Magdalena Wójcik-Superczyńska

View PDF (polish)

Qualification for TKI-EGFR inhibitors treatment in a patient diagnosed with adenocarcinoma of the lung with activating mutation in EGFR gene

Sławomir Mańdziuk, Magdalena Wójcik-Superczyńska

View PDF (polish)

Non-small lung cancer patent with mutations in EGFR gene — diagnostic case

Tomasz Pacuszko

View PDF (polish)

Diagnosis and treatment of female patients with lung cancer in IV stage

Irena Porębska, Bożena Weryńska, Monika Kosacka, Renata Jankowska

View PDF (polish)

Diagnosis of the lung carcinoma in elderly as the multidiciplinary problem

Barbara Rybacka-Chabros

View PDF (polish)

Diagnosis and treatment of patients with NSCLC EGFR Mut+

Ewa Skrzypczyńska

View PDF (polish)

Diagnosis of the patint with stage IV adenocarcinoma of the lung harbouring EGFR activating mutation with the coexisting oligoastrocytoma of the brain

Łukasz Spychalski, Katarzyna Szyszka-Barth

View PDF (polish)

Multiple osteolitic leasions in course of the adenocarcinoma of the lung — diagnostics and treatment

Maja Wasylecka-Morawiec, Adam Płużański

View PDF (polish)

Erlotinib therapy in advanced non small-cell lung cancer

Joanna Gazdulska, Maciej Bryl, Rodryg Ramlau

View PDF (polish)

Metastatic non-small-cell lung cancer with EGFR mutation — case report

Marek Jasiówka, Ida Cedrych

View PDF (polish)

Erlotinib in first-line treatment of 70-years old patient with pulmonary adenocarcinoma

Zygmunt Konieczny

View PDF (polish)

Role of molecularly targeted therapy in the management of advanced non-small-cell lung cancer in the elderly

Barbara Rybacka-Chabros

View PDF (polish)

Second line erlotinib therapy in a non-smoking patient with metastatic non-small-cel lung cancer harbouring EGFR mutation

Marta Skoczek, Grzegorz Czyżewicz

View PDF (polish)

Erlotinib targeted therapy in patient with advanced lung adenocarcinoma

Bożena Weryńska, Irena Porębska, Monika Kosacka, Renata Jankowska

View PDF (polish)